Curated News
By: NewsRamp Editorial Staff
September 16, 2026
Earth Science Tech Q1 2027: Revenue Up 3%, Net Income Jumps 57%
TLDR
- ETST net income surged 57 percent to 715,697 dollars, showing strong profit growth for investors seeking an edge.
- ETST integrates compounding pharmacy, telemedicine, and fulfillment to deliver seamless patient care from consultation to delivery.
- ETST expands healthcare access through telemedicine and pharmacy services, improving patient outcomes and building a better tomorrow.
- ETST revenue hit 9 million dollars as its vertically integrated health platform grew assets 33 percent year over year.
Impact - Why it Matters
The strong financial performance of Earth Science Tech signals a promising trajectory for the company and its investors. The substantial increase in net income and operating cash flow demonstrates that ETST's strategy of acquiring and scaling profitable healthcare businesses is yielding tangible results. As the company continues to expand its telehealth and pharmacy fulfillment platforms, it is well-positioned to capitalize on the growing demand for integrated healthcare services. This news matters because it highlights the potential for sustained growth in the healthcare sector, particularly for companies that can successfully integrate technology and patient care. Investors should take note of ETST's improving financial health and strategic initiatives, which could lead to enhanced shareholder value and greater institutional interest.
Summary
Earth Science Tech (OTC: ETST) has announced its first-quarter fiscal 2027 results, showcasing a robust financial performance that underscores the success of its strategy to acquire and scale profitable healthcare, pharmaceutical, and telemedicine businesses. For the quarter ended June 30, 2026, the company reported a 3% increase in revenue to $9.0 million, a 3.1% rise in gross profit to $6.3 million, and a notable 57% surge in net income to $715,697. Operating cash flow more than doubled to $707,131, and total assets grew by 33.3% to $10.4 million compared to the same period last year. These figures reflect ETST's ability to drive profitability and strengthen its balance sheet while expanding its integrated healthcare platform.
Looking forward, Earth Science Tech plans to pursue geographic expansion, further develop its telehealth and pharmacy fulfillment platforms, enhance operating efficiency, and attract greater institutional investor participation. The company operates as a diversified holding company in the health and wellness sector, building a vertically integrated platform that combines compounding pharmacy operations, telemedicine, clinical support, and direct-to-patient fulfillment. This core value proposition is achieved through specialized subsidiaries that seamlessly integrate patient care from consultation to fulfillment. For a deeper dive into the full article, visit https://ibn.fm/LBl8r.
The announcement was distributed through BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is part of the Dynamic Brand Portfolio @ IBN, which offers a suite of services including wire solutions via InvestorWire, editorial syndication to over 5,000 outlets, press release enhancement, social media distribution, and tailored corporate communications solutions. This comprehensive reach ensures that news like ETST's quarterly results is effectively disseminated to a wide audience of investors, influencers, and the public.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech Q1 2027: Revenue Up 3%, Net Income Jumps 57%
